University of Glasgow
Glasgow, United Kingdom
Dr. Cecilia Ansalone, an early career researcher at the University of Glasgow, completed her Ph.D. in immunology in 2016, focusing on the intricate dynamics of immunological and environmental drivers in chronic inflammatory diseases. Throughout her postdoctoral journey, she strategically expanded her expertise in immunology, tissue culture, molecular biology, and epigenetics, directing them purposefully towards the realm of translational sciences. This deliberate integration, coupled with strategic partnerships with the pharmaceutical industry, has deepened her insights, notably in drug target discovery and validation. Her research interest seamlessly centres on the complexities of understanding pathological tissue destruction and addressing unmet clinical needs in autoimmune diseases. In her ongoing work, particularly on giant cell arteritis, she strengthens her impact in translational sciences by directly interrogating tissue pathology, unveiling the intricacies of autoimmune disorders, and aspiring to contribute to innovative solutions that can directly impact patient care.
Wednesday, November 15, 2023
11:45 AM – 11:55 AM PT
Disclosure information not submitted.
